ÂÜÀòÂÒÂ×

Richard Balla is the CEO of Adjupharm, IMC’s fully-owned German subsidiary and the company’s main European hub. For nearly two decades, Richard has brought his strategic business mindset to senior roles within the German pharmaceutical industry with a specialty in manufacturing, distribution, sales, and the parallel import of pharmaceuticals, medical devices, and cosmetics.

He brings a unique professional background and experience in the German medical cannabis sector. This deep knowledge ensures market entry and expansion understanding to support IMC’s growth plans in Germany and other European jurisdictions that are on the verge of medical cannabis legalization.

Prior to leading Adjupharm, Richard acted as a founder, early-stage shareholder, advisor, and director of multiple international companies in the pharmaceutical and medical cannabis sectors.